In the UK, the National Institute for Health and Care Excellence (NICE) recommends that
women at moderate or high risk of breast cancer be offered risk-reducing medication and …

The development of molecular biomarkers for disease makes it possible for preventative
medicine approaches to be considered. Therefore, therapeutics, treatments, or clinical …

Background To understand the dynamics that limit use of risk-management options by
women at high risk of breast cancer, there is a critical need for research that focuses on …

Effective treatments for rheumatoid arthritis (RA) are available and can lead to remission for
some patients, but most patients remain on potentially toxic and expensive medications in …

Breast cancer is the most common non–skin cancer and the second-leading cause of death
from cancer among women, with an estimated 276 000 new cases diagnosed each year in …

Objectives Aspirin could be offered for colorectal cancer prevention for the UK general
population. To ensure the views of the general population are considered in future …

We undertook a systematic review to synthesise the data on attitudes and behaviour towards
the use of aspirin for cancer prevention, and healthcare providers' attitudes towards …

Background Chemoprevention is one of several methods that have been developed to help
high-risk women reduce their risk of breast cancer. Reasons for the low uptake of …

Medication nonadherence is common and results in avoidable morbidity, mortality, and
burdens on healthcare systems. This paper proposes a preventative approach to medication …

Objective Adjuvant endocrine therapy (AET) reduces the risk of recurrence and mortality in
women with hormone receptor–positive breast cancer. However, adherence to AET remains …